{'fraction_non_alphanumeric': 0.025835866261398176, 'fraction_numerical': 0.0243161094224924, 'mean_word_length': 4.936936936936937, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Topical Cannabadiol in Pain Management: A Call for Formal Clinical Evaluation.

As a medical specialty, pain management is characterized by numerous safety and efficacy issues and many unmet needs. A report by Allied Market Research estimated the 2019 global market for pain relief at $71 billion, with a projected growth rate of nearly 4% per year1 through 2027. The segment of this market most relevant to this discussion, topical pain relief, comprised almost 13% of this market, with a value of $8.9 billion. Higher life expectancy, an aging population and a more comprehensive understanding of pain management are the principal drivers of market growth.